3.63 (-%)
As of Oct 31, 2024
Source:
Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution , is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis .
| Country | United States |
| Headquarters | langhorne, texas |
| Phone Number | (512) 614-1848 |
| Industry | manufacturing |
| CEO | Matthew Pauls |
| Website | www.savarapharma.com |